John Griffin, MD
Colon & Rectal Surgery · Loma Linda, CANPI 1821014903
Payments from drug & device makers
Across 26 payments — averaging $106.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$615
- Stryker$318
- Myriad Genetic Laboratories, Inc.$285
- Baxter Healthcare$260
- Medtronic$162
- Innovation Technologies Inc$145
- plus $983 from 9 others
What the payments were for
- Travel & lodging$1154%
- Food & beverage$2,65296%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $615 |
| Stryker | 2 | $318 |
| Myriad Genetic Laboratories, Inc. | 2 | $285 |
| Baxter Healthcare | 2 | $260 |
| Medtronic(2 entities) | 2 | $162 |
| Innovation Technologies Inc | 1 | $145 |
| Johnson & Johnson | 2 | $142 |
| Axonics, Inc. | 1 | $137 |
| KCI USA, Inc. | 1 | $129 |
| Davol Inc. | 1 | $126 |
| Vertex | 1 | $125 |
| Exact Sciences | 1 | $111 |
| Medical Device Business Services, Inc. | 1 | $80 |
| Cook Medical LLC | 1 | $69 |
| Coopersurgical, Inc. | 1 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$585
- 1788$173
- myRisk$169
- Signia$149
- SPY-PHI SYSTEM$146
- Irrisept$145
- STARLING SYSTEM$140
- Axonics$137
- VAC VERAFLO$129
- PREVENA$129
- Phasix Mesh$126
- JOURNAVX$125
- FLOSEAL$119
- BRACAnalysis CDx$116
- Cologuard Collection Kit$111
How this compares
$2,767 in reported general payments places this provider in the 40th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 69 | $4,271 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 21 | $283 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $158 |
| Neomycin Sulfate | 19 | $90 |
| Metronidazole | 18 | $22 |
| Ondansetron Hcl | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Loma Linda
- Sang LeeLos Angeles$2.6M
- Pamela LeeSan Diego$544K
- Phillip FleshnerWest Hollywood$404K
- Hueylan ChernSan Francisco$328K
- Joseph CarmichaelOrange$179K
- Samuel EisensteinSan Diego$147K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Kyle CologneLos Angeles$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.